Inhibition of GATA2 in prostate cancer by a clinically available small molecule.

Saved in:
Bibliographic Details
Title: Inhibition of GATA2 in prostate cancer by a clinically available small molecule.
Authors: Kaochar S; Department of Medicine, Baylor College of Medicine, Houston, Texas, USA.; Dan L. Duncan Comprehensive Cancer Center, Houston, Texas, USA.; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas, USA., Rusin A; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas, USA., Foley C; Department of Medicine, Baylor College of Medicine, Houston, Texas, USA.; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas, USA., Rajapakshe K; Dan L. Duncan Comprehensive Cancer Center, Houston, Texas, USA.; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas, USA., Robertson M; Dan L. Duncan Comprehensive Cancer Center, Houston, Texas, USA.; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas, USA., Skapura D; Department of Medicine, Baylor College of Medicine, Houston, Texas, USA., Mason C; Department of Medicine, Baylor College of Medicine, Houston, Texas, USA., Berman De Ruiz K; Department of Medicine, Baylor College of Medicine, Houston, Texas, USA., Tyryshkin AM; Department of Medicine, Baylor College of Medicine, Houston, Texas, USA., Deng J; Department of Medicine, Baylor College of Medicine, Houston, Texas, USA., Shin JN; Department of Medicine, Baylor College of Medicine, Houston, Texas, USA., Fiskus W; Department of Medicine, Baylor College of Medicine, Houston, Texas, USA., Dong J; Dan L. Duncan Comprehensive Cancer Center, Houston, Texas, USA.; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas, USA., Huang S; Dan L. Duncan Comprehensive Cancer Center, Houston, Texas, USA.; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas, USA.; Department of Education, Innovation, and Technology, Baylor College of Medicine, Houston, Texas, USA., Navone NM; Division of Cancer Medicine, Department of Genitourinary Medical Oncology, The University of Texas Anderson Cancer Center, Houston, Texas, USA., Davis CM; Avera Institute for Human Genetics, Sioux Falls, South Dakota, USA., Ehli EA; Avera Institute for Human Genetics, Sioux Falls, South Dakota, USA., Coarfa C; Dan L. Duncan Comprehensive Cancer Center, Houston, Texas, USA.; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas, USA., Mitsiades N; Department of Medicine, Baylor College of Medicine, Houston, Texas, USA.; Dan L. Duncan Comprehensive Cancer Center, Houston, Texas, USA.; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas, USA.
Source: Endocrine-related cancer [Endocr Relat Cancer] 2021 Nov 24; Vol. 29 (1), pp. 15-31. Date of Electronic Publication: 2021 Nov 24.
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
Journal Info: Publisher: BioScientifica Country of Publication: England NLM ID: 9436481 Publication Model: Electronic Cited Medium: Internet ISSN: 1479-6821 (Electronic) Linking ISSN: 13510088 NLM ISO Abbreviation: Endocr Relat Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1479-6821
DOI:10.1530/ERC-21-0085